Acute pulmonary thromboembolism, chronic pulmonary thromboembolism
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age >=18 years; 2.Diagnosis of pulmonary thromboembolism in accordance with relevant guidelines; 3.Time from onset to diagnosis <=14 days; 4.Risk stratification classified as intermediate-low risk, intermediate-high risk, or high-risk pulmonary thromboembolism; 5.Written informed consent obtained from the study subject or their legal representative;
Exclusion criteria
Exclusion criteria: 1. Individuals with a previous diagnosis of venous thromboembolism without evidence of recurrence; 2. Individuals unable to undergo electrocardiogram monitoring due to chest surgery, local skin lesions, allergies, or other reasons; 3. Individuals unable to complete follow-up due to illness or living conditions; 4. Individuals with severe cognitive impairment or inability to cooperate with the study procedures.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Follow-up for the occurrence of right ventricular dysfunction at 1 year;;Acute PTE 30-day composite endpoint (all-cause mortality, hemodynamic deterioration, ICU); | — |
Secondary
| Measure | Time frame |
|---|---|
| 6-minute walking distance change;WHO Functional Classification;Changes in BNP levels;Changes in right heart load indicators on imaging;Readmitted within 1 year due to worsening cardiopulmonary function; | — |
Countries
China
Contacts
China-Japan Friendship Hospital